Entorhinal cortex dysfunction in Alzheimer's disease

KM Igarashi - Trends in neurosciences, 2023 - cell.com
The entorhinal cortex (EC) is the brain region that often exhibits the earliest histological
alterations in Alzheimer's disease (AD), including the formation of neurofibrillary tangles and …

[HTML][HTML] Stress-induced biological aging: A review and guide for research priorities

LR Polsky, KE Rentscher, JE Carroll - Brain, behavior, and immunity, 2022 - Elsevier
Exposure to chronic adverse conditions, and the resultant activation of the neurobiological
response cascade, has been associated with an increased risk of early onset of age-related …

[HTML][HTML] Heterogeneity in Alzheimer's disease diagnosis and progression rates: implications for therapeutic trials

R Duara, W Barker - Neurotherapeutics, 2023 - Elsevier
The clinical presentation and the pathological processes underlying Alzheimer's disease
(AD) can be very heterogeneous in severity, location, and composition including the amount …

Role of tau in various tauopathies, treatment approaches, and emerging role of nanotechnology in neurodegenerative disorders

P Kaur, A Khera, HK Alajangi, A Sharma… - Molecular …, 2023 - Springer
A few protein kinases and phosphatases regulate tau protein phosphorylation and an
imbalance in their enzyme activity results in tau hyper-phosphorylation. Aberrant tau …

Alzheimer's targeted treatments: focus on amyloid and inflammation

T Iwatsubo, MC Irizarry, JW Lewcock… - Journal of …, 2023 - Soc Neuroscience
Alzheimer's disease (AD) is the major cause of dementia that is now threatening the lives of
billions of elderly people on the globe, and recent progress in the elucidation of the …

The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer's disease

SH Park, EH Lee, HJ Kim, S Jo, S Lee, SW Seo… - Scientific Reports, 2021 - nature.com
Microglial activation is a central player in the pathophysiology of Alzheimer's disease (AD).
The soluble fragment of triggering receptor expressed on myeloid cells 2 (sTREM2) can …

Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease

S Prins, ML de Kam, CE Teunissen… - Alzheimer's Research & …, 2022 - Springer
Background This study investigated plasma biomarkers for neuroinflammation associated
with Alzheimer's disease (AD) in subjects with preclinical AD compared to healthy elderly …

APOE ε4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain

CJC Huguenard, A Cseresznye, JE Evans… - Current research in …, 2023 - Elsevier
Summary Background The apolipoprotein E (APOE) ε4 allele, involved in fatty acid (FA)
metabolism, is a major genetic risk factor for Alzheimer's disease (AD). This study examined …

Does resistance training in older adults lead to structural brain changes associated with a lower risk of Alzheimer's dementia? A narrative review

L Nicola, SJQ Loo, G Lyon, J Turknett… - Ageing Research Reviews, 2024 - Elsevier
Abstract Dementia, particularly Alzheimer's Disease (AD), has links to modifiable risk factors,
particularly physical inactivity. However, cognitive benefits are generally attributed to aerobic …

CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response

L Duchateau, F Küҫükali, A De Roeck… - Alzheimer's research & …, 2023 - Springer
Abstract Background The Alzheimer's disease (AD) risk gene ABCA7 has suggested
functions in lipid metabolism and the immune system. Rare premature termination codon …